MUSTANG BIO, INC. Purchase Agreements
10 Contracts & Agreements
- Asset Purchase Agreement, dated June 27, 2024, between the Company and uBriGene (Boston) Biosciences, Inc (Filed With SEC on July 3, 2024)
- Form of Securities Purchase Agreement, dated June 19, 2024, by and between the Company and the purchaser party thereto (Filed With SEC on June 24, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on May 2, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on April 29, 2024)
- Form of Securities Purchase Agreement (Filed With SEC on April 2, 2024)
- Form of Securities Purchase Agreement, dated October 26, 2023, by and between the Company and the purchaser party thereto (Filed With SEC on October 30, 2023)
- Second Amendment to Asset Purchase Agreement, dated July 28, 2023, between the Company and uBriGene (Boston) Biosciences, Inc (Filed With SEC on July 31, 2023)
- First Amendment to Asset Purchase Agreement, dated June 29, 2023, between the Company and uBriGene (Boston) Biosciences, Inc (Filed With SEC on June 30, 2023)
- Asset Purchase Agreement, dated May 18, 2023, between the Company and uBriGene (Boston) Biosciences, Inc (Filed With SEC on May 22, 2023)
- UNIT PURCHASE AGREEMENT (Filed With SEC on November 14, 2016)
